SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045938
Filing Date
2019-08-14
Accepted
2019-08-14 16:31:26
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-16859_110q.htm 10-Q 1313837
2 EX-31.1 a19-16859_1ex31d1.htm EX-31.1 9688
3 EX-31.2 a19-16859_1ex31d2.htm EX-31.2 9674
4 EX-32.1 a19-16859_1ex32d1.htm EX-32.1 6351
5 EX-32.2 a19-16859_1ex32d2.htm EX-32.2 6341
  Complete submission text file 0001104659-19-045938.txt   6288115

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT repl-20190630.xml EX-101.INS 1441677
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20190630.xsd EX-101.SCH 52525
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20190630_cal.xml EX-101.CAL 49095
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20190630_def.xml EX-101.DEF 158791
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT repl-20190630_lab.xml EX-101.LAB 465068
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20190630_pre.xml EX-101.PRE 338059
Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 191026932
SIC: 2836 Biological Products, (No Diagnostic Substances)